Washington -- Artecoll, a new item in the increasingly broad array of permanent and semipermanent nonsurgical wrinkle-reduction options, on Feb. 28 took a big step toward FDA approval.
Social Vulnerability Among Individuals With Truncal-Extremity Melanomas Leads to Detriments in Care and Prognosis
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
I Was in a Hurry, and I Was Sued
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
AD Case Study: Topical Steroids Are Not Cutting It
Why Dermatologists Are Not Average Investors
2 Clarke Drive Cranbury, NJ 08512